Table 1 Baseline characteristics presented by entire cohort and by AF status

n

101

66

35

-

Male sex

73 (72.3%)

48 (65.8%)

18 (64.3%)

1.00*

Age, years

58.9 ± 10.9

58.8 ± 11.1

59.1 ± 10.6

0.89

Body surface area, m ²

2.07 ± 0.23

2.04 ± 0.22

2.11 ± 0.26

0.16

Hypertension

39 (38.6%)

25 (37.9%)

14 (40.0%)

0.83*

Beta blocker

46 (45.5%)

26 (39.4%)

20 (57.1%)

0.10*

Digoxin

5 (5.0%)

2 (3.0%)

3 (8.6%)

0.34*

Anti arrhythmic agent

39 (38.6%)

29 (43.9%)

10 (28.6%)

0.14*

HR at time of CMR

69 ± 17

61 ± 9

84 ± 20

<0.0001

HR range, bpm

37-121

37-76

44-121

SBP, mmHg

129 ± 16

132 ± 16

124 ± 15

0.02

DBP, mmHg

73 ± 11

73 ± 10

74 ± 13

0.45

LVEF, %

56.4 ± 11.1

59.5 ± 9.4

49.7 ± 11.6

<0.0001

LVEDVI, ml/m ²

76.7 ± 15.4

78.1 ± 15.9

72.7 ± 13.7

0.16

LVESVI, ml/m ²

33.5 ± 13.5

32.3 ± 13.7

37.0 ± 12.6

0.17

LA diameter, cm

3.9 ± 0.9

3.7 ± 0.7

4.4 ± 0.9

0.0001